Correlation Between Neuropace and Nemaura Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Nemaura Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Nemaura Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Nemaura Medical, you can compare the effects of market volatilities on Neuropace and Nemaura Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Nemaura Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Nemaura Medical.

Diversification Opportunities for Neuropace and Nemaura Medical

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neuropace and Nemaura is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Nemaura Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nemaura Medical and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Nemaura Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nemaura Medical has no effect on the direction of Neuropace i.e., Neuropace and Nemaura Medical go up and down completely randomly.

Pair Corralation between Neuropace and Nemaura Medical

Given the investment horizon of 90 days Neuropace is expected to generate 0.89 times more return on investment than Nemaura Medical. However, Neuropace is 1.12 times less risky than Nemaura Medical. It trades about 0.07 of its potential returns per unit of risk. Nemaura Medical is currently generating about -0.02 per unit of risk. If you would invest  448.00  in Neuropace on November 2, 2024 and sell it today you would earn a total of  971.00  from holding Neuropace or generate 216.74% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy22.67%
ValuesDaily Returns

Neuropace  vs.  Nemaura Medical

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Nemaura Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nemaura Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Nemaura Medical is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Neuropace and Nemaura Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Nemaura Medical

The main advantage of trading using opposite Neuropace and Nemaura Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Nemaura Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nemaura Medical will offset losses from the drop in Nemaura Medical's long position.
The idea behind Neuropace and Nemaura Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Bonds Directory
Find actively traded corporate debentures issued by US companies
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios